Olga Lyass

2.3k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Olga Lyass is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Olga Lyass has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Olga Lyass's work include Cancer Treatment and Pharmacology (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Advanced Radiotherapy Techniques (3 papers). Olga Lyass is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Advanced Radiotherapy Techniques (3 papers). Olga Lyass collaborates with scholars based in Israel, United States and Netherlands. Olga Lyass's co-authors include Alberto Gabizón, Gerald J. Berry, Dinah Tzemach, Michal Lotem, Ayala Hubert, Tamar Safra, Franco M. Muggia, Susan Groshen, Susan Jeffers and Denice Tsao‐Wei and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Olga Lyass

18 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

2000 505 citations Tamar Safra, Franco M. Muggia et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olga Lyass Israel	14	669	570	463	427	380	18	1.8k
J.S.W. Stewart United Kingdom	20	581 0.9×	873 1.5×	435 0.9×	655 1.5×	535 1.4×	36	2.1k
Si Yeol Song South Korea	27	774 1.2×	277 0.5×	1.1k 2.3×	346 0.8×	433 1.1×	157	2.6k
Joseph Treat United States	28	1.4k 2.1×	233 0.4×	1.3k 2.8×	692 1.6×	108 0.3×	102	2.5k
Barbara Haley United States	21	1.7k 2.6×	404 0.7×	629 1.4×	759 1.8×	431 1.1×	56	2.9k
Susan Jeffers United States	18	820 1.2×	535 0.9×	249 0.5×	443 1.0×	282 0.7×	32	2.0k
Johannes S. de Jong Netherlands	13	626 0.9×	159 0.3×	613 1.3×	635 1.5×	966 2.5×	14	2.5k
Everett J. Moding United States	17	388 0.6×	149 0.3×	471 1.0×	435 1.0×	472 1.2×	51	1.6k
Rut Isacson Israel	10	1.3k 1.9×	296 0.5×	441 1.0×	378 0.9×	144 0.4×	22	1.9k
Marlon R. Veldwijk Germany	24	448 0.7×	105 0.2×	264 0.6×	585 1.4×	207 0.5×	60	1.5k
Niels J. Harlaar Netherlands	12	511 0.8×	173 0.3×	567 1.2×	381 0.9×	1.2k 3.1×	23	2.4k

Countries citing papers authored by Olga Lyass

Since Specialization

Citations

This map shows the geographic impact of Olga Lyass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Lyass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Lyass more than expected).

Fields of papers citing papers by Olga Lyass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Lyass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Lyass. The network helps show where Olga Lyass may publish in the future.

Co-authorship network of co-authors of Olga Lyass

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Lyass. A scholar is included among the top collaborators of Olga Lyass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Lyass. Olga Lyass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Gabizón, Alberto, Olga Lyass, Gerald J. Berry, & Mark Wildgust. (2004). Cardiac Safety of Pegylated Liposomal Doxorubicin (Doxil®/Caelyx®) Demonstrated by Endomyocardial Biopsy in Patients with Advanced Malignancies. Cancer Investigation. 22(5). 663–669. 93 indexed citations

2.

Nisman, Benjamin, Vivian Barak, Ayala Hubert, et al.. (2003). Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapy.. PubMed. 23(2C). 1939–42. 15 indexed citations

3.

Mechalakos, James, G Mageras, Michael J. Zeléfsky, et al.. (2002). Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy. Radiotherapy and Oncology. 62(3). 261–265. 29 indexed citations

4.

Lyass, Olga, Ayala Hubert, & Alberto Gabizón. (2001). Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.. PubMed. 7(10). 3040–6. 39 indexed citations

5.

Lotem, Michal, Ayala Hubert, Olga Lyass, et al.. (2000). Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin. Archives of Dermatology. 136(12). 1475–80. 156 indexed citations

6.

Lyass, Olga, Beatrice Uziely, Rami Ben‐Yosef, et al.. (2000). Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer. 89(5). 1037–1047. 323 indexed citations

7.

Hubert, Ayala, Olga Lyass, Dov Pode, & Alberto Gabizón. (2000). Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer. Anti-Cancer Drugs. 11(2). 123–127. 72 indexed citations

8.

Safra, Tamar, Franco M. Muggia, Susan Jeffers, et al.. (2000). Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Annals of Oncology. 11(8). 1029–1034. 505 indexed citations breakdown →

9.

Nisman, Benjamin, G Amir, Joel Lafair, et al.. (2000). Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.. PubMed. 19(4C). 3549–52. 40 indexed citations

10.

Zeléfsky, Michael J., G Mageras, Olga Lyass, et al.. (1999). Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiotherapy and Oncology. 50(2). 225–234. 209 indexed citations

11.

Symon, Zvi, Amos Peyser, Dinah Tzemach, et al.. (1999). Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer. 86(1). 72–78. 169 indexed citations

12.

Symon, Zvi, Amos Peyser, Dinah Tzemach, et al.. (1999). Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer. 86(1). 72–78. 10 indexed citations

13.

Lyass, Olga, Ayala Hubert, Dinah Tzemach, Joel Lafair, & Alberto Gabizon. (1999). Phase I trial of doxil plus cisplatin (DDP) in patients (pt) with advanced malignancies. European Journal of Cancer. 35. S287–S287. 1 indexed citations

14.

Zeléfsky, Michael J., Olga Lyass, Z. Fuks, et al.. (1998). Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.. Journal of Clinical Oncology. 16(10). 3380–3385. 65 indexed citations

15.

Lyass, Olga, et al.. (1998). Cisplatin-induced non-convulsive encephalopathy. Anti-Cancer Drugs. 9(1). 100–104. 27 indexed citations

16.

Nisman, Benjamin, Joel Lafair, Norman Heching, et al.. (1998). Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma. Cancer. 82(10). 1850–1859. 93 indexed citations

17.

Lyass, Olga, et al.. (1997). Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature.. PubMed. 18(1). 68–70. 2 indexed citations

18.

Lyass, Olga, Michael J. Zeléfsky, G Mageras, et al.. (1996). 1012 Quantification of variation in organ position and volume during conformal radiotherapy of the prostate. International Journal of Radiation Oncology*Biology*Physics. 36(1). 250–250. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact